Grants
SOLVO Biotechnology actively takes part in numerous Hungarian grants and European Framework Programs often as consortium leader. You can find below the list of ongoing and completed grants by sponsorship and scheme.
Ongoing Hungarian grants
 |
 |
EUREKA Eurostars
Programme
Development
of a Drug-transporter Specific Ready-to-use Monolayer Cell Product
Line: PreadyPort
Coordinator:
SOLVO Biotechonology
Partners:
Advancell Advaced In vitro Cell Technologies SA
French –Hungarian
(NKTH-ANR) Bilateral Cooperation section Biotechnology
2009
Antimalarial
drug discovery and development of new in vitro assays for the
optimization of antimalaria therapy (ADDMAL09)
Coordinator:
SOLVO Biotechonology
Partners:
L’Universite Montpellier 2, L’ Universite Nice Sophia Antipolis,
Institute Of Enzimology HAS BRC
National
Technology Programme - 2008/1
Development
of in vitro diagnostic test systems for predicting drug-resistance
(IVDMDQ08)
Coordinator:
SOLVO Biotechonology
Partners:
University of Debrecen, Medical and Health Science Center; University
of Pécs, Medical School; University of Szeged, Albert Szent-Györgyi
Clinical Center; 77 Elektronika Ltd; T-Cell Technologies Ltd.,
Laboratory of Tumor Pathology and Molecular Diagnostics
Péter Pázmány
Programme
Leading
edge technologies in the Debrecen University Region: applications in
genomics, nano- and biotechnologies
(RET-06/2004)
Coordinator:
University of Debrecen
Partners:
National Instruments Europe Ltd.; Metalelektro Ltd.; Szinapszis Ltd.;
Labexpert Ltd.; ACROM; Kéri Pharma; Papp-Ker Ltd.Mastergood Ltd.;
Bakonszeg AWASSI; Juhker Ltd.; North Great Plain Regional
Agricultural Innovation and Technology Transfer Centre Non-profit
Company; SANATMETAL Manufacturer of Orthopaedic and Traumatologic
Products; Comgenex Research and Development Inc.; SOLVO
Biotechnology; Experimetria Ltd.; Synonens Research and Development
Ltd.
Ányos Jedlik
Programme
Development
of novel multi-target anti-inflammatory molecules using primary human
phagocyte cellular assay systems
(Inflamin)
Coordinator:
Vichem Chemie Research Ltd.
Partners:
Semmelweis University; Office for Academy Research Groups Attached to
Universities, Peptide Biochemistry Research Group; SOLVO
Biotechnology; University of Debrecen
Complex cell- and membrane vesicle based solution package development for high sensitivity pre-clinical screening of cholestethic compounds (GOP-1.1.1-09/1-2009-0054)
Coordinator: SOLVO Biotechonology
Partners: Chemical Research Center Hungarian Academy of Sciences
Enhancement of
pharmacokinetic parameters of drugs with innovative multivalent
conjugates (GOP-1.1.1-09/1-2009-0055)
Coordinator:
SOLVO Biotechonology
Partners:
University of Szeged, Medical Faculty, Department of Medical
Chemistry
Development of an in vivo technological platform for pharmaceutical applications by enhancing R&D capacities (GOP-1.3.2-09-2010-0008)
Coordinator:
SOLVO Biotechonology
Ongoing EU Framework Programs (FP)
Eustroke -
European stroke research network
Call:
FP7-HEALTH-2007-A
Instrument:
CP-Large Scale Integration Project
Contract
number:
HEALTH-F2-2008-202213
Eustroke
on Cordis
Biosimulation- A
New Tool in Drug Development ("BioSim")
Call:
FP6-2004-LIFESCIHEALTH
Instrument:
NoE
Contract
number:
005137, Co-PI
Biosim
on Cordis
Call: FP6-2004-LIFESCIHEALTH-5
Instrument: NoE
Contract number: 018814, Participant
Eurobonet on Cordis
EC Optimisation
of liver and intestine in vitro models for pharmacokinetics and
pharmacodynamics studies ("LIINTOP")
Call:
FP6-2005-LIFESCIHEALTH-6
Instrument:
STREP
Contract
number:
LSBH-CT-2006-037499, Co-PI
Lintop
on Cordis
Completed Hungarian grants
|
|
László Kozma
Programme
Development
of HTS kit for analyzing transporter-drug interactions using
cholesterol treated insect-cells expressing human MXR
transporter.
Coordinator:
SOLVO Biotechnology.
Partners:
none
Xenobiotic Transporter Technology Platform (XTTP) - Therapeutical and Toxicological Applications (XTTPSRT1)
Coordinator: SOLVO Biotechonology
Partners: University of Szeged; Biological Research Center of the Hungarian Academy of Science; Agricultural Biotechnological Research Centre; LAB Research International Hungary Ltd.; Avidin Ltd.
Oszkár Asbóth
Programme - Focus Sector Innovation Program (FSIP) - 2005
DermaVir
- Vaccine therapy innovation technological cluster
(DermaVir)
Coordinator:
Chemical Research Center Hungarian Academy of Sciences
Partners:
ERCOM Ltd.; GENETIC IMMUNITY Kft.; Semmelweis University, Institute
of Pathophysiology; University of Szeged; SOLVO Biotechnology; L&MARK
Kft.; St. Laszlo Hospital
Péter Pázmány
Program
Neurobiological
Knowledge Center - Therapeutic-Aimed neurobiological researches, from
the molecule to the integrated functioning of the nervous systems
(RET-08/2004)
Coordinator:
University of Szeged
Partners:
Biological Research Center of Szeged of the Hungarian Academy of
Science; Hungarian Academy of Sciences Supported Research Groups;
EGIS Pharmaceuticals; SOLVO Biotechnology; Diagnosticum Inc.; Kromat
Ltd.; Creative Labor Ltd.; Rytmion R&D Ltd.; Kation Europe;
QualiCont In Vitro Diagnostics; South-Plain Bioinnovation Center,
Genomic Laboratory (DIABIC)
National Research
and Development Programmes (NKFP)
Investigation
of cyclodextrin-cell membrane interactions to develop "second
generation" cyclodextrins more efficient in drug formulation
(NKFP-1A/041/2004)
Coordinator:
Cyclolab Research-Development Laboratory Ltd.
Partners:
Solvo Biotechnology; University of Debrecen; HAS- Institute of
Enzimology; University of Szeged, Department of Medical
Chemistry
Development
of molecular therapeutic tools for pharmacological modulation of the
effects of Progesterone Induced Blocking Factor
(NKFP-1A/057/2004)
Coordinator:
Solvo Biotechnology
Partners:
University of Pécs, Faculty of Medicine Dept. Of Microbiology and
Immunology; Biological Research Center of the Hungarian Academy of
Science, Institute of Chemistry; Intercell Biomedical Research and
Development AG; Semmelweis University Cooperative Research Centre,
Rational Drug Design Laboratory; University of Szeged, Department of
Medical Chemistry; University of Szeged, Faculty of Pharmacy, Dept.
Pharmacodynamics and Biopharmacy; KPS Biotechnology Ltd.; L&Mark
Informatika
Development
and application of cell- and gene-therapy methods in medicine
(NKFP-1A/060/2004)
Coordinator:
National Medical Center, Department of Hematology and
Immunology
Partners:
HungAcadSci Institute of Experimental Medicine; Semmelweis
University, Department of Surgery and Transplantion, First Department
of Pediatric; HungAcadSci SzBK Institute of Enzimology, Economy and
Biotechnology Research Center; Diagnostikum Ltd.; Solvo
Biotechnology; MikroVákuum Ltd
Economic Competitiveness Operative Programme (EU Co-financed)
Economic
Competitiveness Operative Programme - 3.3.2- Development of Company
Research Infrastructure
Development
of a novel biopharmacological and diagnostic methods
(GVOP-3.3.2.-2004-04-0001/3.0)
Coordinator:
SOLVO Biotechnology
Economic
Competitiveness Operative Programme - 3.1.1. - Applied Research &
Development - 2004
Development
of a new method based on PIBF measurement to diagnose malignant
tumours and threatening abortion
(GVOP-3.1.1.-2004-05-0329/3.0)
Coordinator:
University of Pécs
Partners:
SOLVO Biotechnology; Cooperative Research Center (SE)
In
vitro pharmacokinetics; Development of high-through-put systems
suitable for in vitro ADME-Tox investigations (vesicular-transport,
ATP-ase and cellular model systems)
(GVOP-3.1.1.-2004-05-0506/3.0)
Coordinator:
SOLVO Biotechnology
Partners:
HungAcadSci- Department of Enzimology, BRC
Development
of cellular model systems expressing multidrug resistant proteins for
the biological characterization of protein kinase inhibitors
(GVOP-3.1.1.-2004-05-0467/3.0)
Coordinator:
Semmelweis University (Budapest)
Partners:
Cooperative Research Center (SE); National medical Center; Solvo
Biotechnology; Vichem Chemie Ltd.
Development
of in silico and in vitro methods for the prediction of multidrug
resistance and penetration of blood-brain barrier
(GVOP-3.1.1.-2004-05-0440/3.0)
Coordinator:
ComGenex Ltd.
Partners:
Solvo Biotechnology; University of Debrecen; ComGrid Ltd.
Multidrug
Resistance Kit in rheumatoid arthritis
(GVOP-3.1.1.-2004-05-0243/3.0)
Coordinator:
Semmelweis University (Budapest)
Partners:
County Hospital, Kecskemét; Solvo Biotechnology; Goodwill Research
Ltd.
Economic
Competitiveness Operative Programme - 3.2.2. - Cooperative Research
Centers - 2004
Establishment
of the Human Biotechnological Research and Educational Center
(GVOP-3.2.2.-2004-07-0015/3.0)
Coordinator:
National Medical Center
Partners:
Department of Medical Chemistry, Institute of Pathobiochemical and
Molecular Biology, Semmelweis University; Department of Organic
Chemistry, Eötvös Lóránd University of Science; Institute of
Enzimology, Hungarian Academy of Sciences; Cytobiology Laboratory,
Institute of Experimental Medical Science Research, Hungarian Academy
of Sciences; Diagnosticum Ltd.; Solvo Biotechnology; Institute of
Isotopes Co., Ltd.; Creative Development Deposit Company; GENOMED
Ltd.; Csertex Ltd.; TRIGON Ltd.
Economic
Competitiveness Operative Programme - 3.3.3 "Funding Company
Innovation"
Development
of assay systems to study the interaction of test drugs with SLC
uptake transporters
(GVOP-3.3.3-05/1.-2005-05-0118/3.0)
Beneficiary:
Solvo Biotechnology
Economic
Competitiveness Operative Programme - 3.3.2 - Development of Company
Research Infrastructure
Supporting
research infrastructure for the development of assay systems to study
the interaction of test drugs with SLC uptake transporters
(GVOP-3.3.2-05/1.-2005-05-0015/3.0)
Beneficiary:
Solvo Biotechnology
Completed EU Framework Programs (FP)
Non-viral gene transfer ("INTHER")
Call: FP6-2004-LIFESCIHEALTH-5
Instrument: STREP
Contract number: LSBH-CT-2005-018961 Co-PI
Inther on Cordis
Membrane
transporters: In vitro models for the study of their role in drug
fate ("MEMTRANS")
Call:
FP6-2004-LIFESCIHEALTH-5
Instrument:
STREP
Contract
number:
518246, Co-PI
Memtrans
on Cordis
Towards
new diagnostic standards - development of a protein based diagnostic
assay and of a novel anti-abortion drug target (PIBF)
Call:
FP6-2003-SME-1
Instrument:
CRAFT,
Contract
number:
018814COOP-CT-2004-508141
Pibf
on Cordis